| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.22 | 0.4 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.2 | 0.4 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.051 | 0.4 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |